Although one study found that current soy isoflavone supplements were associated with an increased risk of ER‐breast cancer and a decreased risk of estrogen receptor positive (ER+) breast cancer, two Western studies that evaluated soy or soy isoflavone supplements did not find any association between soy or soy isoflavone supplements and overall breast cancer risk. This evidence concerns the gene ESR1 and breast carcinoma.